Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis

被引：0
|
作者：
Inna Tabansky
Mark D. Messina
Catherine Bangeranye
Jeffrey Goldstein
Karen M. Blitz-Shabbir
Suly Machado
Venkatesh Jeganathan
Paul Wright
Souhel Najjar
Yonghao Cao
Warren Sands
Derin B. Keskin
Joel N. H. Stern
机构：
[1] The Rockefeller University,Department of Neurobiology and Behavior
[2] Hofstra North Shore-LIJ School of Medicine,Department of Neurology
[3] Hofstra North Shore-LIJ School of Medicine,Department of Science Education
[4] North Shore-LIJ Health System,Department of Autoimmunity, The Feinstein Institute for Medical Research
[5] Harvard University,School of Engineering and Applied Sciences
[6] University of Pittsburgh Medical Center,Department of Medicine
[7] Dana Farber-Harvard Cancer Institute,Department of Cancer Immunology and AIDS
来源：
Immunologic Research | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：640 / 640
相关论文
共 50 条
  • [31] Drug delivery systems for the treatment of restenosis
    Chorny, M
    Fishbein, I
    Golomb, G
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2000, 17 (03): : 249 - 284
  • [32] Drug delivery systems for tuberculosis treatment
    Batyrbekov, EO
    Rukhina, LB
    Zhubanov, BA
    Bekmukhamedova, NF
    Smailova, GA
    POLYMER INTERNATIONAL, 1997, 43 (04) : 317 - 320
  • [33] Nanomaterial-Based Drug Delivery Systems for Pain Treatment and Relief: From the Delivery of a Single Drug to Co-Delivery of Multiple Therapeutics
    Xu, Yuhang
    Dong, Xingpeng
    Xu, Heming
    Jiao, Peifu
    Zhao, Lin-Xia
    Su, Gaoxing
    PHARMACEUTICS, 2023, 15 (09)
  • [34] Multiple sclerosis is at a checkpoint: advancing the program
    Smith, Brandon C.
    Williams, Jessica L.
    NEURAL REGENERATION RESEARCH, 2025, 20 (03) : 811 - 812
  • [35] Multiple sclerosis is at a checkpoint: advancing the program
    Brandon C.Smith
    Jessica L.Williams
    Neural Regeneration Research, 2025, 20 (03) : 811 - 812
  • [36] Mergers and acquisitions - Advancing drug delivery
    不详
    CHEMICAL ENGINEERING PROGRESS, 2002, 98 (01) : 21 - 21
  • [37] Erratum: Multiple sclerosis—a quiet revolution
    Richard M. Ransohoff
    David A. Hafler
    Claudia F. Lucchinetti
    Nature Reviews Neurology, 2015, 11 : 246 - 246
  • [38] Repurposing the multiple sclerosis drug Siponimod for osteoporosis treatment
    Hu, Sitao
    Hu, Yangyang
    Tan, Zenglin
    Zhou, Chengyu
    Zhang, Cheng
    Yin, Sheng
    Chen, Xiaojun
    Chen, Kai
    Wang, Lu
    Chen, Lei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 974
  • [39] Immunomodulatory Drug Treatment in Multiple Sclerosis: Effect on Survival
    Orion, David
    Chapman, Joab
    Dolev, Mark
    Tsabari, Rakefet
    Achiron, Anat
    NEUROLOGY, 2009, 72 (11) : A241 - A241
  • [40] Drug treatment of multiple sclerosis - Clinical review was unsystematic
    Milne, R
    Clegg, A
    Bryant, J
    BRITISH MEDICAL JOURNAL, 2001, 322 (7281): : 299 - 299
12345